Key result
Adenosine infusion achieved a similar fall in pulmonary vascular resistance as sodium nitroprusside but a greater fall in transpulmonary pressure gradient (35% vs 9%, p<0.02) in biventricular failure.
Why the study?
Does adenosine infusion improve pulmonary hemodynamics compared to sodium nitroprusside in patients with end-stage biventricular heart failure?
Population
Patients with end-stage biventricular heart failure referred for orthotopic heart transplantation.
Comparison
Adenosine infusion with 30% oxygen via face mask. vs Sodium nitroprusside infusion with 30% oxygen…
Design
Cohort
Authors
Loading...
Adenosine may aid acute testing of pulmonary vasoreactivity in biventricular failure; leaves open its comparative role versus nitroprusside in prospective studies.
Does adenosine infusion improve pulmonary hemodynamics compared to sodium nitroprusside in patients with end-stage biventricular heart failure?
Absolute Event Rate: 35% vs 9%
p-value: p=<0.02
Adenosine is a potent selective pulmonary vasodilator useful for testing reversibility of pulmonary vasoconstriction in biventricular heart failure, but its tendency to increase left atrial pressure makes it unsuitable for chronic therapy.
Haywood et al. (1992) studied End-stage biventricular heart failure (n=39). Adenosine infusion vs. Sodium nitroprusside was evaluated on Percentage fall in transpulmonary pressure gradient (p=<0.02). Adenosine infusion achieved a similar fall in pulmonary vascular resistance as sodium nitroprusside but a greater fall in transpulmonary pressure gradient (35% vs 9%, p<0.02) in biventricular failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: